Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Net Income (2020 - 2025)

Historic Net Income for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to -$11.5 million.

  • Rapid Micro Biosystems' Net Income fell 160.73% to -$11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$44.3 million, marking a year-over-year increase of 847.81%. This contributed to the annual value of -$46.9 million for FY2024, which is 1063.14% up from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Net Income of -$11.5 million as of Q3 2025, which was down 160.73% from -$11.9 million recorded in Q2 2025.
  • Over the past 5 years, Rapid Micro Biosystems' Net Income peaked at -$9.7 million during Q4 2024, and registered a low of -$25.0 million during Q3 2021.
  • Its 5-year average for Net Income is -$14.1 million, with a median of -$13.3 million in 2024.
  • Its Net Income has fluctuated over the past 5 years, first crashed by 19518.02% in 2021, then skyrocketed by 3461.0% in 2022.
  • Rapid Micro Biosystems' Net Income (Quarter) stood at -$14.6 million in 2021, then decreased by 12.73% to -$16.5 million in 2022, then soared by 32.14% to -$11.2 million in 2023, then rose by 13.48% to -$9.7 million in 2024, then fell by 19.03% to -$11.5 million in 2025.
  • Its Net Income stands at -$11.5 million for Q3 2025, versus -$11.9 million for Q2 2025 and -$11.3 million for Q1 2025.